genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Synthetic Biology
Flush with Cash, Foresite Aims to Live Up to Its Name
OMICs
From Genomes to Drugs: An Interview with Vertex CSO David Altshuler
Gene Therapy
AI Gets Gene Therapy Over the Immunity Hump
Coronavirus
Immunai Expands from Observational to Functional Genomics
Antibody Drug Conjugates
RNA in Its DNA: Avidity Biosciences Combines mAb Selectivity, Oligonucleotide Precision
News
Drug Discovery
ICON to Acquire PRA for $12B, as COVID-19 Spurs CRO Consolidation
Artificial Intelligence
AI Joins Forces with fMRI to Decode Brain Dynamics Underlying Neurofeedback
Neuroscience
First Compound That Potentially Halts Degeneration of Neurons in ALS Identified
Aging
Scientists Identify Mechanism Linking Exercise with Bone Strength and Immunity
Biomarkers
Genetic Method Improves Estimating Prostate Cancer Risk in Multi-Ethnic Groups
Insights
All
Trends for 2021
Trends for 2020
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
Insights
COVID-19 Increasing Risk of Cyberattacks for Digital Biopharma
Insights
Case Study: How to Accelerate COVID-19 Vaccine Development
Insights
Flexibility is Key to Advances in Biomanufacturing
A-Lists
A-Lists
Top 7 Best Selling COVID-19 Vaccines and Drugs of 2020
Insights
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
Insights
Top 10 Earners among Women Biopharma Executives
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Synthetic Biology
Flush with Cash, Foresite Aims to Live Up to Its Name
Drug Discovery
ICON to Acquire PRA for $12B, as COVID-19 Spurs CRO Consolidation
Biomarkers
Genetic Method Improves Estimating Prostate Cancer Risk in Multi-Ethnic Groups
Cancer
Blocking a Treg Mechanism Can Scorch Tumors without Stoking Autoimmunity
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Insights
Page 3
Insights
Featured posts
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Insights
Forces Unite to Move Molecular Dx Out of the Gates
Insights
Genome Editing Heads to Primetime
Insights
One-Stop-Shop Genome Editing Product Launched by Inscripta
Insights
Going Viral: The Next Generation of AAV Vectors
Insights
Genetics of Same-Sex Behavior Revealed
Insights
DOLPHIN Imaging System Dives into Early Cancer Detection
Insights
Selfish Genetic Elements Hasten Aging Process
Insights
Cutting-Edge Biotechs Need Cutting-Edge Software
Insights
Small Tau Filaments Yield Big CTE Discovery
Insights
Fishing for Mutations Using CRISPR-Chip
Insights
Confidence in Cell Therapy Development
Insights
Top 10 Immuno-Oncology Startups of 2018
Insights
Breaking New Ground in Liquid Biopsy
Insights
He Jiankui’s Germline Editing Ethics Article Retracted by The CRISPR Journal
Insights
Eyeing Epigenetics
1
2
3
4
...
10
Page 3 of 10
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Firm had previously rejected Astellas’ unsolicited bid of roughly $3.5 billion. [© Yuri Arcurs - Fotolia.com]](https://www.genengnews.com/wp-content/uploads/2018/08/May17_2010_495175_HandshakeBirdsEyeView_AstellasBuysOSI7721122207-2.jpg "Forces Unite to Move Molecular Dx Out of the Gates")
